{
  "meta": {
    "disclaimer": "openFDA is a beta research project and not for clinical use. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.",
    "license": "http://open.fda.gov/license",
    "last_updated": "2015-01-21",
    "results": {
      "skip": 0,
      "limit": 100,
      "total": 7
    }
  },
  "results": [
    {
      "dataset": "drug/event",
      "safetyreportid": "6251678-1",
      "fulfillexpeditecriteria": "1",
      "receiver": null,
      "receivedateformat": "102",
      "receiptdateformat": "102",
      "receivedate": "20090630",
      "primarysource": {
        "qualification": "2",
        "reportercountry": "IRELAND"
      },
      "sender": {
        "senderorganization": "FDA-Public Use"
      },
      "@epoch": 1417048845.306429,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "MALAISE"
          },
          {
            "reactionmeddrapt": "VOMITING"
          }
        ],
        "patientonsetage": "5",
        "patientweight": "16",
        "patientonsetageunit": "801",
        "drug": [
          {
            "drugauthorizationnumb": "50698",
            "drugstartdateformat": "102",
            "drugbatchnumb": "UNKNOWN",
            "drugcharacterization": "1",
            "drugindication": "HELICOBACTER INFECTION",
            "medicinalproduct": "KLACID FOR ORAL SUSPENSION",
            "drugstartdate": "20090507"
          },
          {
            "drugauthorizationnumb": "050698",
            "drugbatchnumb": "UNKNOWN",
            "drugcharacterization": "1",
            "medicinalproduct": "KLACID FOR ORAL SUSPENSION",
            "drugdosagetext": "HALF A TABLET CRUSHED, TOOK WITH ICE CREAM"
          },
          {
            "drugstartdateformat": "102",
            "drugbatchnumb": "UNKNOWN",
            "drugcharacterization": "1",
            "drugindication": "HELICOBACTER INFECTION",
            "medicinalproduct": "PINAMOX",
            "drugstartdate": "20090507"
          },
          {
            "drugcharacterization": "2",
            "drugindication": "HELICOBACTER INFECTION",
            "medicinalproduct": "PRILOSEC",
            "openfda": {
              "unii": [
                "KG60484QX9"
              ],
              "spl_id": [
                "00b7d931-923e-4fdb-9736-e75e96ad3859"
              ],
              "product_ndc": [
                "0186-0742",
                "0186-0606",
                "0186-0625",
                "0186-0610",
                "0186-0743"
              ],
              "substance_name": [
                "OMEPRAZOLE MAGNESIUM"
              ],
              "rxcui": [
                "797061",
                "797063",
                "797058",
                "207212",
                "199119",
                "198051",
                "213295",
                "211691",
                "200329",
                "797065"
              ],
              "spl_set_id": [
                "a1b077e6-b070-43f2-a98e-380cc635419d"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "manufacturer_name": [
                "AstraZeneca LP"
              ],
              "brand_name": [
                "PRILOSEC"
              ],
              "route": [
                "ORAL"
              ],
              "nui": [
                "N0000175525",
                "N0000182140",
                "N0000000147"
              ],
              "pharm_class_moa": [
                "Proton Pump Inhibitors [MoA]",
                "Cytochrome P450 2C19 Inhibitors [MoA]"
              ],
              "package_ndc": [
                "0186-0743-82",
                "0186-0606-82",
                "0186-0742-31",
                "0186-0743-68",
                "0186-0742-82",
                "0186-0610-01",
                "0186-0743-31",
                "0186-0606-31",
                "0186-0625-01"
              ],
              "pharm_class_epc": [
                "Proton Pump Inhibitor [EPC]"
              ],
              "generic_name": [
                "OMEPRAZOLE MAGNESIUM"
              ],
              "application_number": [
                "NDA019810",
                "NDA022056"
              ]
            }
          }
        ],
        "patientsex": "2"
      },
      "receiptdate": "20090622",
      "transmissiondate": "20091009",
      "transmissiondateformat": "102",
      "seriousnesshospitalization": "1",
      "serious": "1",
      "companynumb": "IE-ABBOTT-09P-229-0581634-00"
    },
    {
      "dataset": "drug/event",
      "safetyreportid": "9122050",
      "fulfillexpeditecriteria": "2",
      "receiver": {
        "receiverorganization": "FDA",
        "receivertype": "6"
      },
      "duplicate": "1",
      "receivedateformat": "102",
      "reportduplicate": {
        "duplicatesource": "AFFYMAX",
        "duplicatenumb": "2012US-004450"
      },
      "reporttype": "1",
      "receiptdateformat": "102",
      "primarysource": {
        "qualification": "3",
        "reportercountry": "US"
      },
      "receivedate": "20130125",
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "primarysourcecountry": "US",
      "@epoch": 1417048845.306429,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "Blood pressure decreased",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Headache",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Chest pain",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Hypersensitivity",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Dyspnoea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Angioedema",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Malaise",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Nausea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Vomiting",
            "reactionmeddraversionpt": "16.1"
          }
        ],
        "patientonsetage": "46",
        "patientonsetageunit": "801",
        "drug": [
          {
            "drugauthorizationnumb": "202799",
            "drugstartdateformat": "102",
            "drugcharacterization": "1",
            "drugindication": "NEPHROGENIC ANAEMIA",
            "medicinalproduct": "OMONTYS (PEGINESATIDE) SOLUTION FOR INJECTION",
            "drugadministrationroute": "042",
            "drugstructuredosagenumb": "2.5",
            "drugstartdate": "20121002",
            "drugenddate": "20121103",
            "drugstructuredosageunit": "003",
            "drugenddateformat": "102"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HEPARIN (HEPARIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VENOFER",
            "openfda": {
              "unii": [
                "FZ7NYF5N8L"
              ],
              "spl_id": [
                "d3e872e0-b2d7-473b-be86-c593b4fda3f2",
                "c5a93448-024c-4920-8226-9ddf746e30e7"
              ],
              "product_ndc": [
                "0517-2325",
                "49230-530",
                "0517-2340",
                "0517-2310",
                "49230-534"
              ],
              "substance_name": [
                "IRON SUCROSE"
              ],
              "rxcui": [
                "283517",
                "284502"
              ],
              "spl_set_id": [
                "626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a",
                "f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "pharm_class_cs": [
                "Iron [Chemical/Ingredient]"
              ],
              "manufacturer_name": [
                "American Regent, Inc.",
                "Fresenius Medical Care North America"
              ],
              "brand_name": [
                "VENOFER"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "nui": [
                "N0000177913",
                "N0000006237"
              ],
              "package_ndc": [
                "49230-530-10",
                "0517-2340-01",
                "0517-2340-99",
                "0517-2340-10",
                "49230-534-10",
                "0517-2325-10",
                "49230-534-25",
                "0517-2340-25",
                "0517-2310-05",
                "49230-530-25"
              ],
              "pharm_class_epc": [
                "Parenteral Iron Replacement [EPC]"
              ],
              "generic_name": [
                "IRON SUCROSE"
              ],
              "application_number": [
                "NDA021135"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ZEMPLAR (PARICALCITOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "NITROGLYCERIN (GLYCERYL TRINITRATE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BODY QUEST ICE CREAM"
          }
        ],
        "patientsex": "2"
      },
      "receiptdate": "20130125",
      "transmissiondate": "20140127",
      "transmissiondateformat": "102",
      "safetyreportversion": "1",
      "serious": "2",
      "companynumb": "2012US-004450"
    },
    {
      "dataset": "drug/event",
      "fulfillexpeditecriteria": "1",
      "safetyreportid": "9122574",
      "receiver": {
        "receiverorganization": "FDA",
        "receivertype": "6"
      },
      "duplicate": "1",
      "receivedateformat": "102",
      "reportduplicate": {
        "duplicatesource": "AFFYMAX",
        "duplicatenumb": "2013US-004581"
      },
      "reporttype": "1",
      "receiptdateformat": "102",
      "primarysource": {
        "qualification": "3",
        "reportercountry": "US"
      },
      "receivedate": "20130222",
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "seriousnessdeath": "1",
      "primarysourcecountry": "US",
      "@epoch": 1417048845.306429,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "Cardiac arrest",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Burning sensation",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Dyspnoea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Cyanosis",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Unresponsive to stimuli",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Haemoglobin decreased",
            "reactionmeddraversionpt": "16.1"
          }
        ],
        "patientonsetage": "50",
        "patientweight": "98",
        "patientonsetageunit": "801",
        "drug": [
          {
            "drugauthorizationnumb": "202799",
            "drugstartdateformat": "102",
            "drugcharacterization": "1",
            "drugindication": "NEPHROGENIC ANAEMIA",
            "medicinalproduct": "OMONTYS (PEGINESATIDE) SOLUTION FOR INJECTION",
            "drugadministrationroute": "042",
            "drugstructuredosagenumb": "15",
            "drugdosagetext": "15 MG, Q 4 WEEKS, INTRAVENOUS",
            "drugstartdate": "20130212",
            "drugenddate": "20130212",
            "drugstructuredosageunit": "003",
            "drugenddateformat": "102"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LANTUS (INSULIN GLARGINE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HUMALOG (INSULIN LISPRO)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TRAMADOL (TRAMADOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ASPIRIN (ACETYLSALICYLIC ACID)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "COREG",
            "openfda": {
              "unii": [
                "0K47UL67F2"
              ],
              "spl_id": [
                "85ba9af4-cafa-4bec-8e69-03914484e2fb",
                "e387006e-1cc8-4bdc-9e60-8ba56941542f"
              ],
              "product_ndc": [
                "0007-4139",
                "0007-4140",
                "0007-4141",
                "0007-4142",
                "0007-3371",
                "0007-3372",
                "0007-3373",
                "0007-3370"
              ],
              "substance_name": [
                "CARVEDILOL PHOSPHATE",
                "CARVEDILOL"
              ],
              "rxcui": [
                "212388",
                "212389",
                "860532",
                "200031",
                "860510",
                "200033",
                "200032",
                "860524",
                "860522",
                "860518",
                "686924",
                "686926",
                "212390",
                "860534",
                "860512",
                "860516"
              ],
              "spl_set_id": [
                "06400a4c-42b4-440a-92b4-1f47f98ac7ba",
                "c57982f2-c7da-488a-7ea9-b9609439ac68"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "manufacturer_name": [
                "GlaxoSmithKline LLC"
              ],
              "brand_name": [
                "COREG CR",
                "COREG"
              ],
              "route": [
                "ORAL"
              ],
              "nui": [
                "N0000009924",
                "N0000175556",
                "N0000000099",
                "N0000009923",
                "N0000175553"
              ],
              "pharm_class_moa": [
                "Adrenergic beta2-Antagonists [MoA]",
                "Adrenergic beta1-Antagonists [MoA]",
                "Adrenergic alpha-Antagonists [MoA]"
              ],
              "package_ndc": [
                "0007-4141-20",
                "0007-4142-20",
                "0007-3370-13",
                "0007-3372-13",
                "0007-3371-13",
                "0007-3371-61",
                "0007-3370-61",
                "0007-4140-20",
                "0007-3373-61",
                "0007-4139-20",
                "0007-3373-13"
              ],
              "pharm_class_epc": [
                "alpha-Adrenergic Blocker [EPC]",
                "beta-Adrenergic Blocker [EPC]"
              ],
              "generic_name": [
                "CARVEDILOL PHOSPHATE",
                "CARVEDILOL"
              ],
              "application_number": [
                "NDA022012",
                "NDA020297"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "EPOGEN (EPOETIN ALFA)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VENOFER",
            "openfda": {
              "unii": [
                "FZ7NYF5N8L"
              ],
              "spl_id": [
                "d3e872e0-b2d7-473b-be86-c593b4fda3f2",
                "c5a93448-024c-4920-8226-9ddf746e30e7"
              ],
              "product_ndc": [
                "0517-2325",
                "49230-530",
                "0517-2340",
                "0517-2310",
                "49230-534"
              ],
              "substance_name": [
                "IRON SUCROSE"
              ],
              "rxcui": [
                "283517",
                "284502"
              ],
              "spl_set_id": [
                "626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a",
                "f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "pharm_class_cs": [
                "Iron [Chemical/Ingredient]"
              ],
              "manufacturer_name": [
                "American Regent, Inc.",
                "Fresenius Medical Care North America"
              ],
              "brand_name": [
                "VENOFER"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "nui": [
                "N0000177913",
                "N0000006237"
              ],
              "package_ndc": [
                "49230-530-10",
                "0517-2340-01",
                "0517-2340-99",
                "0517-2340-10",
                "49230-534-10",
                "0517-2325-10",
                "49230-534-25",
                "0517-2340-25",
                "0517-2310-05",
                "49230-530-25"
              ],
              "pharm_class_epc": [
                "Parenteral Iron Replacement [EPC]"
              ],
              "generic_name": [
                "IRON SUCROSE"
              ],
              "application_number": [
                "NDA021135"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BODY QUEST ICE CREAM"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HEPARIN (HEPARIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ZEMPLAR (PARICALCITOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CLONIDINE (CLONIDINE)"
          }
        ],
        "patientsex": "1"
      },
      "receiptdate": "20130415",
      "transmissiondate": "20140414",
      "transmissiondateformat": "102",
      "safetyreportversion": "2",
      "serious": "1",
      "companynumb": "2013US-004581"
    },
    {
      "dataset": "drug/event",
      "fulfillexpeditecriteria": "2",
      "safetyreportid": "9199296",
      "receiver": {
        "receiverorganization": "FDA",
        "receivertype": "6"
      },
      "duplicate": "1",
      "receivedateformat": "102",
      "reportduplicate": {
        "duplicatesource": "AFFYMAX",
        "duplicatenumb": "2012US-004579"
      },
      "reporttype": "1",
      "receiptdateformat": "102",
      "primarysource": {
        "qualification": "3",
        "reportercountry": "US"
      },
      "receivedate": "20130325",
      "seriousnessother": "1",
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "primarysourcecountry": "US",
      "@epoch": 1417048845.306429,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "Somnolence",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Disorientation",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Aggression",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Cold sweat",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Dyspnoea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Blood pressure decreased",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Loss of consciousness",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Hypersensitivity",
            "reactionmeddraversionpt": "16.1"
          }
        ],
        "patientonsetage": "69",
        "patientweight": "101",
        "patientonsetageunit": "801",
        "drug": [
          {
            "drugadditional": "1",
            "drugauthorizationnumb": "202799",
            "drugbatchnumb": "C18881",
            "drugstartdateformat": "102",
            "medicinalproduct": "OMONTYS (PEGINESATIDE) SOLUTION FOR INJECTION",
            "drugindication": "NEPHROGENIC ANAEMIA",
            "drugstructuredosageunit": "003",
            "drugcharacterization": "1",
            "drugstructuredosagenumb": "15",
            "drugadministrationroute": "042",
            "drugstartdate": "20130201",
            "drugenddate": "20130201",
            "drugenddateformat": "102"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TACROLIMUS (TACROLIMUS)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HEPARIN (HEPARIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HEPARIN (HEPARIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BODY QUEST ICE CREAM"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VENOFER",
            "openfda": {
              "unii": [
                "FZ7NYF5N8L"
              ],
              "spl_id": [
                "d3e872e0-b2d7-473b-be86-c593b4fda3f2",
                "c5a93448-024c-4920-8226-9ddf746e30e7"
              ],
              "product_ndc": [
                "0517-2325",
                "49230-530",
                "0517-2340",
                "0517-2310",
                "49230-534"
              ],
              "substance_name": [
                "IRON SUCROSE"
              ],
              "rxcui": [
                "283517",
                "284502"
              ],
              "spl_set_id": [
                "626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a",
                "f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "pharm_class_cs": [
                "Iron [Chemical/Ingredient]"
              ],
              "manufacturer_name": [
                "American Regent, Inc.",
                "Fresenius Medical Care North America"
              ],
              "brand_name": [
                "VENOFER"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "nui": [
                "N0000177913",
                "N0000006237"
              ],
              "package_ndc": [
                "49230-530-10",
                "0517-2340-01",
                "0517-2340-99",
                "0517-2340-10",
                "49230-534-10",
                "0517-2325-10",
                "49230-534-25",
                "0517-2340-25",
                "0517-2310-05",
                "49230-530-25"
              ],
              "pharm_class_epc": [
                "Parenteral Iron Replacement [EPC]"
              ],
              "generic_name": [
                "IRON SUCROSE"
              ],
              "application_number": [
                "NDA021135"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ZEMPLAR (PARICALCITOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HYDROCODONE (HYDROCODONE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LORAZEPAM (LORAZEPAM)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "METHOCARBAMOL (METHOCARBAMOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CLONAZEPAM (CLONAZEPAM)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "PRADAXA (DABIGATRAN ETEXILATE MESILATE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FLOMAX (TAMSULOSIN HYDROCHLORIDE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LEVOTHYROXINE (LEVOTHYROXINE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LANTUS (INSULIN GLARGINE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ASPIRIN (ACETYLSALICYLIC ACID)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CARVEDILOL (CARVEDILOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SODIUM BICARBONATE (SODIUM BICARBONATE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LASIX (FUROSEMIDE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "OXYGEN (OXYGEN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "REQUIP (ROPINIROLE HYDROCHLORIDE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TEMAZEPAM (TEMAZEPAM)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ATARAX (HYDROXYZINE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "AMBIEN (ZOLPIDEM TARTRATE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "OMEPRAZOLE (OMEPRAZOLE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FENOFIBRATE (FENOFIBRATE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "LEVAQUIN (LEVOFLOXACIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "EPOGEN (EPOETIN ALFA)"
          }
        ],
        "patientsex": "1"
      },
      "receiptdate": "20130325",
      "transmissiondate": "20140127",
      "transmissiondateformat": "102",
      "safetyreportversion": "1",
      "serious": "1",
      "companynumb": "2012US-004579"
    },
    {
      "dataset": "drug/event",
      "fulfillexpeditecriteria": "2",
      "safetyreportid": "9199312",
      "receiver": {
        "receiverorganization": "FDA",
        "receivertype": "6"
      },
      "duplicate": "1",
      "receivedateformat": "102",
      "reportduplicate": {
        "duplicatesource": "AFFYMAX",
        "duplicatenumb": "2013US-004599"
      },
      "reporttype": "1",
      "receiptdateformat": "102",
      "primarysource": {
        "qualification": "3",
        "reportercountry": "US"
      },
      "receivedate": "20130325",
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "primarysourcecountry": "US",
      "@epoch": 1417048845.306429,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "Vascular graft thrombosis",
            "reactionmeddraversionpt": "16.1"
          }
        ],
        "patientonsetage": "72",
        "patientonsetageunit": "801",
        "drug": [
          {
            "drugauthorizationnumb": "202799",
            "drugbatchnumb": "C19258",
            "drugstartdateformat": "102",
            "medicinalproduct": "OMONTYS",
            "drugindication": "NEPHROGENIC ANAEMIA",
            "drugstructuredosageunit": "003",
            "drugcharacterization": "1",
            "drugseparatedosagenumb": "1",
            "drugstructuredosagenumb": "10",
            "drugadministrationroute": "042",
            "drugintervaldosageunitnumb": "1",
            "drugstartdate": "20130212",
            "drugintervaldosagedefinition": "802",
            "drugenddate": "20130212",
            "drugenddateformat": "102"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FLEXERIL (CYCLOBENZAPRINE HYDROCHLORIDE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CALCIUM (CALCIUM)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SERTRALINE (SERTRALINE) (SERTRALINE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ASPIRIN (ACETYLSALICYLIC ACID)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SIMVASTATIN (SIMVASTATIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VENOFER",
            "openfda": {
              "unii": [
                "FZ7NYF5N8L"
              ],
              "spl_id": [
                "d3e872e0-b2d7-473b-be86-c593b4fda3f2",
                "c5a93448-024c-4920-8226-9ddf746e30e7"
              ],
              "product_ndc": [
                "0517-2325",
                "49230-530",
                "0517-2340",
                "0517-2310",
                "49230-534"
              ],
              "substance_name": [
                "IRON SUCROSE"
              ],
              "rxcui": [
                "283517",
                "284502"
              ],
              "spl_set_id": [
                "626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a",
                "f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "pharm_class_cs": [
                "Iron [Chemical/Ingredient]"
              ],
              "manufacturer_name": [
                "American Regent, Inc.",
                "Fresenius Medical Care North America"
              ],
              "brand_name": [
                "VENOFER"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "nui": [
                "N0000177913",
                "N0000006237"
              ],
              "package_ndc": [
                "49230-530-10",
                "0517-2340-01",
                "0517-2340-99",
                "0517-2340-10",
                "49230-534-10",
                "0517-2325-10",
                "49230-534-25",
                "0517-2340-25",
                "0517-2310-05",
                "49230-530-25"
              ],
              "pharm_class_epc": [
                "Parenteral Iron Replacement [EPC]"
              ],
              "generic_name": [
                "IRON SUCROSE"
              ],
              "application_number": [
                "NDA021135"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HEPARIN (HEPARIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "EPOGEN (EPOETIN ALFA)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TRAZODONE (TRAZODONE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CARVEDILOL (CARVEDILOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "PANTOPRAZOLE (PANTOPRAZOLE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BODY QUEST ICE-CREAM"
          }
        ],
        "patientsex": "2"
      },
      "receiptdate": "20130415",
      "transmissiondate": "20140414",
      "transmissiondateformat": "102",
      "safetyreportversion": "2",
      "seriousnesshospitalization": "1",
      "serious": "1",
      "companynumb": "2013US-004599"
    },
    {
      "dataset": "drug/event",
      "safetyreportid": "9236508",
      "fulfillexpeditecriteria": "1",
      "receiver": {
        "receiverorganization": "FDA",
        "receivertype": "6"
      },
      "duplicate": "1",
      "receivedateformat": "102",
      "reportduplicate": {
        "duplicatesource": "AFFYMAX",
        "duplicatenumb": "2013US-004578"
      },
      "reporttype": "1",
      "receiptdateformat": "102",
      "primarysource": {
        "qualification": "3",
        "reportercountry": "US"
      },
      "receivedate": "20130415",
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "primarysourcecountry": "US",
      "@epoch": 1417048845.306429,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "Chest pain",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Hypoaesthesia",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Dyspnoea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Diarrhoea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Vomiting",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Nausea",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Pruritus",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Drug hypersensitivity",
            "reactionmeddraversionpt": "16.1"
          },
          {
            "reactionmeddrapt": "Device occlusion",
            "reactionmeddraversionpt": "16.1"
          }
        ],
        "patientonsetage": "72",
        "patientweight": "70",
        "patientonsetageunit": "801",
        "drug": [
          {
            "drugauthorizationnumb": "202799",
            "drugbatchnumb": "C19258",
            "drugstartdateformat": "102",
            "medicinalproduct": "OMONTYS (PEGINESATIDE) SOLUTION FOR INJECTION",
            "drugindication": "NEPHROGENIC ANAEMIA",
            "drugdosagetext": "10 MG, Q 4 WEEKS, INTRAVENOUS",
            "drugstructuredosageunit": "003",
            "drugcharacterization": "1",
            "drugstructuredosagenumb": "10",
            "drugadministrationroute": "042",
            "drugstartdate": "20130212",
            "drugenddate": "20130212",
            "drugenddateformat": "102"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "FLEXERIL (CYCLOBENZAPRINE HYDROCHLORIDE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CALCIUM (CALCIUM)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SERTRALINE (SERTRALINE) (SERTRALINE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "ASPIRIN (ACETYLSALCYLIC ACID)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "SIMVASTATIN (SIMVASTATIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "VENOFER",
            "openfda": {
              "unii": [
                "FZ7NYF5N8L"
              ],
              "spl_id": [
                "d3e872e0-b2d7-473b-be86-c593b4fda3f2",
                "c5a93448-024c-4920-8226-9ddf746e30e7"
              ],
              "product_ndc": [
                "0517-2325",
                "49230-530",
                "0517-2340",
                "0517-2310",
                "49230-534"
              ],
              "substance_name": [
                "IRON SUCROSE"
              ],
              "rxcui": [
                "283517",
                "284502"
              ],
              "spl_set_id": [
                "626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a",
                "f1ab1a22-2b99-4d27-8b5a-9c3bcd5e3040"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "pharm_class_cs": [
                "Iron [Chemical/Ingredient]"
              ],
              "manufacturer_name": [
                "American Regent, Inc.",
                "Fresenius Medical Care North America"
              ],
              "brand_name": [
                "VENOFER"
              ],
              "route": [
                "INTRAVENOUS"
              ],
              "nui": [
                "N0000177913",
                "N0000006237"
              ],
              "package_ndc": [
                "49230-530-10",
                "0517-2340-01",
                "0517-2340-99",
                "0517-2340-10",
                "49230-534-10",
                "0517-2325-10",
                "49230-534-25",
                "0517-2340-25",
                "0517-2310-05",
                "49230-530-25"
              ],
              "pharm_class_epc": [
                "Parenteral Iron Replacement [EPC]"
              ],
              "generic_name": [
                "IRON SUCROSE"
              ],
              "application_number": [
                "NDA021135"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "HEPARIN (HEPARIN)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "EPOGEN (EPOETIN ALFA)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "BODY QUEST ICE CREAM"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TRAZODONE (TRAZODONE)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "CARVEDILOL (CARVEDILOL)"
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "PANTOPRAZOLE (PANTOPRAZOLE)"
          }
        ],
        "patientsex": "2"
      },
      "receiptdate": "20130415",
      "transmissiondate": "20140414",
      "transmissiondateformat": "102",
      "safetyreportversion": "1",
      "serious": "2",
      "companynumb": "2013US-004578"
    },
    {
      "dataset": "drug/event",
      "fulfillexpeditecriteria": "2",
      "safetyreportid": "9968957",
      "receiver": {
        "receiverorganization": "FDA",
        "receivertype": "6"
      },
      "duplicate": "1",
      "receivedateformat": "102",
      "reportduplicate": {
        "duplicatesource": "ABBVIE",
        "duplicatenumb": "US-ABBVIE-13P-163-1143476-00"
      },
      "reporttype": "2",
      "receiptdateformat": "102",
      "primarysource": {
        "qualification": "5",
        "reportercountry": "COUNTRY NOT SPECIFIED"
      },
      "receivedate": "20140306",
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "primarysourcecountry": "US",
      "@epoch": 1417462781.564311,
      "patient": {
        "reaction": [
          {
            "reactionmeddrapt": "No therapeutic response",
            "reactionmeddraversionpt": "17.0",
            "reactionoutcome": "1"
          }
        ],
        "drug": [
          {
            "drugauthorizationnumb": "125057",
            "drugbatchnumb": "231172E",
            "drugcharacterization": "1",
            "actiondrug": "1",
            "drugindication": "RHEUMATOID ARTHRITIS",
            "medicinalproduct": "HUMIRA",
            "drugadministrationroute": "058",
            "drugstructuredosagenumb": "40",
            "openfda": {
              "unii": [
                "FYS6T7F842"
              ],
              "spl_id": [
                "d567f091-3867-2149-abf5-f5dc7c330b65"
              ],
              "product_ndc": [
                "0074-4339",
                "0074-3797",
                "0074-9374",
                "0074-3799"
              ],
              "substance_name": [
                "ADALIMUMAB"
              ],
              "rxcui": [
                "351290",
                "727705",
                "727703",
                "352334",
                "825170",
                "763565",
                "763564",
                "825169"
              ],
              "spl_set_id": [
                "608d4f0d-b19f-46d3-749a-7159aa5f933d"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "manufacturer_name": [
                "AbbVie Inc."
              ],
              "brand_name": [
                "HUMIRA"
              ],
              "route": [
                "SUBCUTANEOUS"
              ],
              "nui": [
                "N0000175451",
                "N0000175610"
              ],
              "pharm_class_moa": [
                "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"
              ],
              "package_ndc": [
                "0074-4339-02",
                "0074-4339-06",
                "0074-4339-07",
                "0074-9374-71",
                "0074-3799-02",
                "0074-4339-73",
                "0074-4339-71",
                "0074-3799-71",
                "0074-3797-01",
                "0074-9374-02"
              ],
              "pharm_class_epc": [
                "Tumor Necrosis Factor Blocker [EPC]"
              ],
              "generic_name": [
                "ADALIMUMAB"
              ],
              "application_number": [
                "BLA125057"
              ]
            },
            "drugstructuredosageunit": "003",
            "drugdosageform": "Solution for injection in pre-filled pen"
          },
          {
            "drugcharacterization": "2",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "medicinalproduct": "LEFLUNOMIDE",
            "drugstructuredosagenumb": "20",
            "openfda": {
              "unii": [
                "G162GK9U4W"
              ],
              "spl_id": [
                "d5b7c6ef-43b9-4058-936f-6f8ced6b003a",
                "1d044024-733a-4c91-a415-035c4c7a47a1",
                "d552460d-424d-4185-b359-016a4ccf5cd3",
                "cece7c0f-bc65-4d68-8df7-86faf545ddd2",
                "4a67eff2-e3bd-4486-b718-d57fa45cf01a",
                "332aeb48-8a1a-4d50-be12-05411b7a2967",
                "03ab0fd4-fe51-4279-b5f6-437ef3808c17",
                "fe1ea007-6d6e-1d29-5bd0-6ac7174b6136"
              ],
              "product_ndc": [
                "13811-677",
                "23155-043",
                "0088-2161",
                "0093-0173",
                "0093-0174",
                "23155-044",
                "0781-5056",
                "0781-5057",
                "0088-2160",
                "13811-678",
                "16714-331",
                "16714-321",
                "60505-2502",
                "60505-2503",
                "66993-160",
                "66993-161",
                "0088-2162"
              ],
              "substance_name": [
                "LEFLUNOMIDE"
              ],
              "rxcui": [
                "213379",
                "213380",
                "213377",
                "205285",
                "205284",
                "205286"
              ],
              "spl_set_id": [
                "d3a4788f-6ff4-4804-9b41-7d6f0b27cd5c",
                "2dba6c8e-3c51-4762-ae27-dcd760783f9b",
                "40dd071a-d07f-452f-bf1a-2a23b9d22ca4",
                "753453c5-8a7a-878e-3ce7-1d1edce718a9",
                "332aeb48-8a1a-4d50-be12-05411b7a2967",
                "e2f051ce-c4e4-43a1-9732-fe0a777a6951",
                "320f63f2-fac3-4aee-aff8-85724e00ef52",
                "b933c448-a7e5-4f38-b5e2-a03615826fa3"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "manufacturer_name": [
                "Trigen Laboratories, LLC",
                "Heritage Pharmaceuticals Inc",
                "sanofi-aventis U.S. LLC",
                "Apotex Corp.",
                "NorthStar RxLLC",
                "Sandoz Inc",
                "Prasco LLC",
                "Teva Pharmaceuticals USA Inc"
              ],
              "brand_name": [
                "LEFLUNOMIDE",
                "ARAVA"
              ],
              "route": [
                "ORAL"
              ],
              "nui": [
                "N0000175713"
              ],
              "package_ndc": [
                "60505-2503-1",
                "60505-2503-2",
                "60505-2503-3",
                "13811-677-10",
                "13811-677-30",
                "13811-678-10",
                "23155-043-03",
                "0781-5056-01",
                "23155-043-05",
                "60505-2502-2",
                "13811-678-60",
                "0781-5057-10",
                "0088-2162-33",
                "0781-5057-31",
                "0088-2161-30",
                "0093-0174-56",
                "66993-161-30",
                "13811-677-60",
                "23155-044-05",
                "0781-5056-10",
                "23155-044-03",
                "16714-321-01",
                "13811-678-30",
                "0781-5057-01",
                "13811-678-50",
                "60505-2502-1",
                "60505-2502-3",
                "16714-321-04",
                "66993-160-30",
                "0781-5056-31",
                "0093-0173-56",
                "16714-331-04",
                "13811-677-50",
                "16714-321-03",
                "16714-321-02",
                "0088-2160-30",
                "16714-331-01",
                "16714-331-02",
                "16714-331-03"
              ],
              "pharm_class_epc": [
                "Antirheumatic Agent [EPC]"
              ],
              "generic_name": [
                "LEFLUNOMIDE"
              ],
              "application_number": [
                "NDA020905",
                "ANDA091369",
                "ANDA077090",
                "ANDA077084",
                "ANDA077086",
                "ANDA077087"
              ]
            },
            "drugstructuredosageunit": "003"
          },
          {
            "drugcharacterization": "2",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "medicinalproduct": "DIOVAN",
            "drugstructuredosagenumb": "160",
            "openfda": {
              "unii": [
                "80M03YXJ7I"
              ],
              "spl_id": [
                "aacd310a-f272-4364-9e9f-4ced3ad0d8f9"
              ],
              "product_ndc": [
                "0078-0423",
                "0078-0358",
                "0078-0359",
                "0078-0360"
              ],
              "substance_name": [
                "VALSARTAN"
              ],
              "rxcui": [
                "349483",
                "352001",
                "352274",
                "349200",
                "349201",
                "349199",
                "351761",
                "351762"
              ],
              "spl_set_id": [
                "5ddba454-f3e6-43c2-a7a6-58365d297213"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "manufacturer_name": [
                "Novartis Pharmaceuticals Corporation"
              ],
              "brand_name": [
                "DIOVAN"
              ],
              "route": [
                "ORAL"
              ],
              "nui": [
                "N0000175561",
                "N0000000070"
              ],
              "pharm_class_moa": [
                "Angiotensin 2 Receptor Antagonists [MoA]"
              ],
              "package_ndc": [
                "0078-0359-06",
                "0078-0360-06",
                "0078-0359-61",
                "0078-0423-15",
                "0078-0360-11",
                "0078-0360-34",
                "0078-0358-61",
                "0078-0360-61",
                "0078-0359-34",
                "0078-0423-06",
                "0078-0358-06",
                "0078-0358-33",
                "0078-0423-61",
                "0078-0359-17",
                "0078-0358-34"
              ],
              "pharm_class_epc": [
                "Angiotensin 2 Receptor Blocker [EPC]"
              ],
              "generic_name": [
                "VALSARTAN"
              ],
              "application_number": [
                "NDA021283"
              ]
            },
            "drugstructuredosageunit": "003"
          },
          {
            "drugcharacterization": "2",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "medicinalproduct": "LYRICA",
            "drugstructuredosagenumb": "75",
            "openfda": {
              "spl_id": [
                "acba4ee8-32fd-42e9-a2c6-6e3f28184267",
                "97ad1752-d9b5-460f-b49c-c7551e70f07e"
              ],
              "product_ndc": [
                "0071-1012",
                "0071-1013",
                "0071-1014",
                "0071-1015",
                "0071-1016",
                "0071-1017",
                "0071-1018",
                "0071-1019",
                "63539-014",
                "63539-013",
                "0071-1020"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "PREGABALIN"
              ],
              "rxcui": [
                "607038",
                "577127",
                "607018",
                "483438",
                "898718",
                "898715",
                "607033",
                "607028",
                "607024",
                "607026",
                "483448",
                "607022",
                "607020",
                "483442",
                "483440",
                "483450",
                "483446",
                "483444"
              ],
              "spl_set_id": [
                "ce1a4b9d-3127-4416-8bf2-fee5899fc0ba",
                "60185c88-ecfd-46f9-adb9-b97c6b00a553"
              ],
              "package_ndc": [
                "0071-1018-68",
                "0071-1016-41",
                "0071-1012-68",
                "0071-1014-41",
                "0071-1019-68",
                "63539-014-90",
                "63539-013-41",
                "0071-1014-68",
                "0071-1015-41",
                "0071-1015-68",
                "0071-1016-68",
                "0071-1020-01",
                "0071-1013-68",
                "0071-1013-41",
                "0071-1017-68"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "generic_name": [
                "PREGABALIN"
              ],
              "manufacturer_name": [
                "Parke-Davis Div of Pfizer Inc",
                "U.S. Pharmaceuticals"
              ],
              "brand_name": [
                "LYRICA"
              ],
              "application_number": [
                "NDA021446",
                "NDA021724",
                "NDA022488"
              ]
            },
            "drugstructuredosageunit": "003"
          },
          {
            "drugcharacterization": "2",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "medicinalproduct": "ZANTAC",
            "drugstructuredosagenumb": "150",
            "openfda": {
              "unii": [
                "884KT10YB7"
              ],
              "spl_id": [
                "2675f3d4-72e4-4abb-86b4-35b89f75a1cd",
                "f6e057d6-ec9a-45da-ba74-0ebda3fa873c",
                "82ff9ee1-b4a7-440d-9045-93551ec429e9"
              ],
              "product_ndc": [
                "0173-0383",
                "0173-0393",
                "24987-362",
                "24987-364",
                "24987-363",
                "0173-0344"
              ],
              "substance_name": [
                "RANITIDINE HYDROCHLORIDE"
              ],
              "rxcui": [
                "198193",
                "198191",
                "705610",
                "312772",
                "827185",
                "755272",
                "104084",
                "827189"
              ],
              "spl_set_id": [
                "7159badb-315f-4d1d-804a-49624b168c31",
                "da7dbbe1-4f2d-4466-9573-8d239d112998",
                "08010bf7-1f61-48b3-e1b5-7cecb72ba863"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "manufacturer_name": [
                "GlaxoSmithKline LLC",
                "Covis Pharmaceuticals, Inc."
              ],
              "brand_name": [
                "ZANTAC"
              ],
              "route": [
                "INTRAMUSCULAR",
                "ORAL",
                "INTRAVENOUS"
              ],
              "nui": [
                "N0000000151",
                "N0000175784"
              ],
              "pharm_class_moa": [
                "Histamine H2 Receptor Antagonists [MoA]"
              ],
              "package_ndc": [
                "0173-0383-54",
                "0173-0344-14",
                "0173-0393-40",
                "0173-0344-42",
                "24987-362-10",
                "24987-363-01",
                "24987-364-01"
              ],
              "pharm_class_epc": [
                "Histamine-2 Receptor Antagonist [EPC]"
              ],
              "generic_name": [
                "RANITIDINE HYDROCHLORIDE"
              ],
              "application_number": [
                "NDA019090",
                "NDA018703"
              ]
            },
            "drugstructuredosageunit": "003"
          },
          {
            "drugcharacterization": "2",
            "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION",
            "medicinalproduct": "GRD ICE CREAM"
          }
        ],
        "patientsex": "2"
      },
      "receiptdate": "20140306",
      "transmissiondate": "20141002",
      "transmissiondateformat": "102",
      "occurcountry": "US",
      "safetyreportversion": "1",
      "serious": "2",
      "companynumb": "US-ABBVIE-13P-163-1143476-00"
    }
  ]
}